<i>In Vivo</i> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
Kurt Selle(North Carolina State University), David G. Ousterout(Profectus Biosciences (United States)), Hannah H. Tuson(Profectus Biosciences (United States)), Lana McMillan, Casey M. Theriot(North Carolina State University), Gowrinarayani S. Vridhambal, Louis‐Charles Fortier(Université de Sherbrooke), Stephanie A. Montgomery(University of Pittsburgh), Rodolphe Barrangou(North Carolina State University), Alissa J. Rivera(North Carolina State University), Daniel Schmitt, Joshua R. Fletcher(North Carolina State University)
Cited by 220
Related Papers
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
|Science|2007|6.3k
Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
|Proceedings of the National Academy of Sciences|2012|2.8k
An updated evolutionary classification of CRISPR–Cas systems
|Nature Reviews Microbiology|2015|2.6k
Evolution and classification of the CRISPR–Cas systems
|Nature Reviews Microbiology|2011|2.5k
CRISPR/Cas, the Immune System of Bacteria and Archaea
|Science|2010|2.5k